Sato Akinori, Kamekura Ryuta, Kawata Koji, Kawada Masaya, Jitsukawa Sumito, Yamashita Keiji, Sato Noriyuki, Himi Tetsuo, Ichimiya Shingo
Department of Human Immunology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
PLoS One. 2016 Jul 1;11(7):e0158408. doi: 10.1371/journal.pone.0158408. eCollection 2016.
Leptin is a hormone produced by adipose tissue that regulates various physiological processes. Recent studies have shown that the level of circulating leptin is elevated in obese patients and have suggested a relationship between obesity and postoperative lymphedema. However, the mechanisms by which postoperative lymphedema develops in obese patients and the mechanisms by which leptin regulates lymphatic endothelial cell homeostasis such as tube formation and cell proliferation remain unknown. Here we report that leptin regulates tube formation and cell proliferation in human dermal lymphatic endothelial cells (HDLECs) by activation of the signal transducer and activator of transcription 3 pathway, which is downstream signaling of the leptin receptor. Additionally, we found that upregulation of suppressor of cytokine signaling 3 underlies the mechanisms by which a high dose of leptin inhibits cell proliferation and tube formation. Leptin also enhanced expression of the proinflammatory cytokine IL-6 in HDLECs. Interestingly, IL-6 rescues the compromised cell proliferation and tube formation caused by treatment with a high dose of leptin in an autocrine or paracrine manner. Taken together, our findings reveal a novel mechanism by which compromised HDLECs maintain their homeostasis during inflammation mediated by leptin and IL-6. Thus, regulating the level of leptin or IL-6 may be a viable strategy to reduce the incidence of postoperative lymphedema.
瘦素是一种由脂肪组织产生的激素,可调节多种生理过程。最近的研究表明,肥胖患者循环中的瘦素水平升高,并提示肥胖与术后淋巴水肿之间存在关联。然而,肥胖患者术后淋巴水肿的发生机制以及瘦素调节淋巴管内皮细胞稳态(如管腔形成和细胞增殖)的机制仍不清楚。在此,我们报告瘦素通过激活信号转导子和转录激活子3通路来调节人真皮淋巴管内皮细胞(HDLEC)的管腔形成和细胞增殖,该通路是瘦素受体的下游信号。此外,我们发现细胞因子信号抑制因子3的上调是高剂量瘦素抑制细胞增殖和管腔形成的机制基础。瘦素还增强了HDLEC中促炎细胞因子IL-6的表达。有趣的是,IL-6以自分泌或旁分泌方式挽救了高剂量瘦素处理导致的细胞增殖和管腔形成受损。综上所述,我们的研究结果揭示了一种新机制,即受损的HDLEC在瘦素和IL-6介导的炎症过程中维持其稳态。因此,调节瘦素或IL-6水平可能是降低术后淋巴水肿发生率的可行策略。